PFS
PMVP icon

Prospera Financial Services’s PMV Pharmaceuticals PMVP Stock Holding History

Prospera Financial Services’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-136
Closed -$2K – 1389
2022
Q2 		$2K Hold
136
– – ﹤0.01% 1560
2022
Q1 		$3K Buy
+136
New +$2.4K ﹤0.01% 2409

Other funds holding PMVP

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return

Prospera Financial Services's PMVP Position: Q3 2022 in Review

Prospera Financial Services sold out of PMV Pharmaceuticals (PMVP) in Q3 2022, closing a stake of 136 shares — an estimated $2K sold.

Prospera Financial Services first reported a position in PMVP in Q1 2022 and held it in 2 quarters. The position peaked at $3K in Q1 2022. 120 funds tracked by Wall St. Rank hold PMVP as of Q3 2022.

  • Prospera Financial Services reported no remaining PMV Pharmaceuticals position as of Q3 2022 after selling out during the quarter.
  • Prospera Financial Services sold 136 PMV Pharmaceuticals shares in Q3 2022, an estimated $2K.
  • Prospera Financial Services first reported a position in PMV Pharmaceuticals in Q1 2022 and held it in 2 quarters.
  • Prospera Financial Services's PMV Pharmaceuticals position peaked at $3K in Q1 2022.
  • 120 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2022.

Based on Prospera Financial Services's 13F filing for Q3 2022, filed 27 Oct 2022.